Naphthazarin enhances ionizing radiation-induced cell cycle arrest and apoptosis in human breast cancer cells

Min Young Kim, Seong‐Joon Park, Jae Woong Shim, Kwangmo Yang, Ho Sung Kang, Kyu HeoInternational Journal of Oncology 2015 · DOI

Abstract

Naphthazarin (Naph, DHNQ, 5,8-dihydroxy-l,4-naphthoquinone) is one of the naturally available 1,4-naphthoquinone derivatives that are well-known for their anti-inflammatory, antioxidant, antibacterial and antitumor cytotoxic effects in cancer cells. Herein, we investigated whether Naph has effects on cell cycle arrest and apoptosis in MCF-7 human breast cancer cells exposed to ionizing radiation (IR). Naph reduced the MCF-7 cell viability in a dose-dependent manner. We also found that Naph and/or IR increased the p53-dependent p21 (CIP/WAF1) promoter activity. Noteworthy, our ChIP assay results showed that Naph and IR combined treatment activated the p21 promoter via inhibition of binding of multi-domain proteins, DNMT1, UHRF1 and HDAC1. Apoptosis and cell cycle analyses demonstrated that Naph and IR combined treatment induced cell cycle arrest and apoptosis in MCF-7 cells. Herein, we showed that Naph treatment enhances IR-induced cell cycle arrest and death in MCF-7 human breast cancer cells through the p53-dependent p21 activation mechanism. These results suggest that Naph might sensitize breast cancer cells to radiotherapy by enhancing the p53-p21 mechanism activity.

Introduction

Breast cancer remains a leading cause of mortality among women, often due to the development of resistance to standard treatments such as ionizing radiation (IR). To overcome this challenge, researchers are actively seeking "radiosensitizers"—adjuvant compounds that can enhance the efficacy of radiation therapy without increasing systemic toxicity. Naphthazarin (Naph), a naturally occurring 1,4-naphthoquinone derivative, has emerged as a candidate due to its known anti-inflammatory and antitumor properties. This study investigates the potential of Naph to sensitize MCF-7 breast cancer cells to IR and elucidates the underlying molecular mechanisms.

Methods

The study utilized the MCF-7 human breast cancer cell line. Researchers employed a variety of molecular biology techniques, including MTT assays for cell viability, phase-contrast microscopy for morphological assessment, and quantitative RT-PCR and Western Blotting for gene and protein expression analysis. Chromatin Immunoprecipitation (ChIP) was used to determine protein binding at the p21 gene promoter. Additionally, flow cytometry was performed to quantify cell cycle distribution and apoptosis rates.

Results

Dose-Dependent Cytotoxicity of Naphthazarin

Initial experiments established that Naphthazarin treatment alone significantly reduces the viability of MCF-7 cells. As shown in the dose-response analysis, cell survival decreases in a clear dose-dependent manner as Naph concentrations increase from 0.1 µM to 5 µM.

Dose-dependent reduction in MCF-7 cell survival following Naphthazarin treatment.

Synergistic Radiosensitization and Cell Cycle Arrest

The combination of Naph (1 µM) and IR (10 Gy) demonstrated a potent synergistic effect. While radiation alone induced some cell death, the addition of Naph significantly enhanced these effects over 24, 48, and 72 hours. The combination treatment resulted in a late apoptosis rate of 43.9% and nearly doubled the proportion of cells arrested in the G2/M phase (31.2%) compared to control groups.

Time-dependent cell survival showing the synergistic effect of Naphthazarin (N) and Radiation (Ra) compared to control (C).

Molecular Mechanism: Releasing the Epigenetic Brake

Mechanistically, the study found that Naph and IR combined treatment activates the p21 promoter by inhibiting the binding of a repressive epigenetic complex consisting of DNMT1, UHRF1, and HDAC1. In cancer cells, this complex typically acts as a "brake" on the p21 gene. Naph treatment facilitates the dissociation of these repressive factors, allowing the tumor suppressor protein p53 to bind to the promoter and drive high levels of p21 expression, ultimately leading to cell cycle arrest and apoptosis.

Discussion and Conclusion

These findings suggest that Naphthazarin acts as a powerful radiosensitizer in breast cancer cells by modulating the p53-p21 signaling axis through epigenetic regulation. By removing the repressive "brake" on the p21 gene, Naph allows radiation to more effectively trigger programmed cell death. While these in vitro results are promising, future work must validate these findings in more heterogeneous breast cancer models and in vivo systems to fully characterize the clinical potential and safety profile of Naphthazarin as a radiotherapy adjuvant.

Summary updated

Abstract

Naphthazarin (Naph, DHNQ, 5,8-dihydroxy-l,4-naphthoquinone) is one of the naturally available 1,4-naphthoquinone derivatives that are well-known for their anti-inflammatory, antioxidant, antibacterial and antitumor cytotoxic effects in cancer cells. Herein, we investigated whether Naph has effects on cell cycle arrest and apoptosis in MCF-7 human breast cancer cells exposed to ionizing radiation (IR). Naph reduced the MCF-7 cell viability in a dose-dependent manner. We also found that Naph and/or IR increased the p53-dependent p21 (CIP/WAF1) promoter activity. Noteworthy, our ChIP assay results showed that Naph and IR combined treatment activated the p21 promoter via inhibition of binding of multi-domain proteins, DNMT1, UHRF1 and HDAC1. Apoptosis and cell cycle analyses demonstrated that Naph and IR combined treatment induced cell cycle arrest and apoptosis in MCF-7 cells. Herein, we showed that Naph treatment enhances IR-induced cell cycle arrest and death in MCF-7 human breast cancer cells through the p53-dependent p21 activation mechanism. These results suggest that Naph might sensitize breast cancer cells to radiotherapy by enhancing the p53-p21 mechanism activity.
BibTeX
@article{kim2015naphthazarin,
  author = {Min Young Kim and Seong‐Joon Park and Jae Woong Shim and Kwangmo Yang and Ho Sung Kang and Kyu Heo},
  title = {{Naphthazarin enhances ionizing radiation-induced cell cycle arrest and apoptosis in human breast cancer cells}},
  journal = {International Journal of Oncology},
  year = {2015},
  doi = {10.3892/ijo.2015.2857},
}
Figure